FDA inspection
Chengdu Shengnuo Biopharm Co., Ltd.: FDA inspection ending Sep 8, 2023
FDA inspection 1219460 · Voluntary Action Indicated (VAI) · Chengdu
Key facts
| Inspection ID | 1219460 |
|---|---|
| Firm | Chengdu Shengnuo Biopharm Co., Ltd. |
| FEI number | 3006257504 |
| Address | Section 1, Gongye Avenue, Dayi County |
| City | Chengdu |
| Country | China |
| Fiscal year | 2023 |
| Inspection end date | Sep 8, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data